First Ever Truly Contactless Glaucoma Monitoring – Anytime, Anywhere.

IOPerfect™'s breakthrough AI technology enables contactless, fast and safe intraocular pressure monitoring – easily self-administered tele-diagnosis

IOPerfect™ Advantages

Self administered

no eye drops

Truly contact-free

AI-based, truly

Fast, safe and painless: under 3 mins

Fast, safe
and takes only
90 seconds

User-friendly: affordable and simple

painless, simple and affordable

Any time of day: as needed

Any time of day:
either sitting or supine

Clinically reliable

reliable method

The Need

Glaucoma: The Silent Thief of Sight

Glaucoma is a common chronic disease caused by elevated intraocular pressure (IOP) that can cause damage to the optic nerve if left untreated. 

Current methods to monitor IOP, the key biomarker for glaucoma, only permit measurements by a professional in a clinic or hospital, usually every few months, while other available home monitoring devices are either highly invasive and/or lack reliability and cost-efficacy.

Since IOP fluctuates, even throughout the day, such infrequent and limited testing gives an incomplete picture. This may lead to sub-optimal treatment and challenges in adjusting therapy in a timely manner.

The Need

Glaucoma in Numbers

0 M


0 %

of the adult population
have glaucoma

# 0

cause of adult

0 %

of true glaucoma patients
are undiagnosed

Breakthrough Remote Intraocular
Monitoring Technology

We have developed a proprietary device and method to remotely monitor IOP using Artificial Intelligence-based visual analysis of ocular vascular pressure response.

Patients can easily and safely use our smart visor to monitor their IOP at any time of day at home or work. Nominal, controlled air pressure is applied within the visor while micro-video cameras capture the difference in response to pressure of internal vs. external blood vessels. Our AI algorithm analyses the processed videos to calculate the patient’s IOP. The results are immediately transmitted and accessible to the clinician for interpretation.

Our unparalleled contactless technology would be the first ideal IOP tracking solution to allow better glaucoma management, improving patient outcomes and improving economics for patients, clinics, hospitals and payers.

This cutting edge technology forms the basis for our future products, including a full eye-care remote diagnostics suite for early detection of cataract, exophthalmia, ocular motor disorders,  visual field and more.

IOP Detection

About Us

Ophthalmic Sciences aims to cross the last frontier in eye care: user-friendly remote glaucoma monitoring. Founded in 2019, the company is led by a team of medical and business veterans along with AI and image processing experts.

Targeting the $7 billion glaucoma market, Ophthalmic Sciences will work to expand its proprietary platform technology to include additional eyecare applications, such as for early detection of cataract & corneal edema and for the early identification of central/branch vascular occlusions and ocular motor disorders.

The company is part of eHealth Ventures, an accelerator providing access to world class clinical, operational and business networks.

Team and Advisory Board


Ariel Weinstein, MSM, EMT-P


Noam Hadas, MA, MSc
Founder & CTO

Dr. Joseph Rosenblum, MD

Dr. Joseph Rosenblum, MD
Medical Director

Prof. David Goldblum, MD
Board Member & Senior Advisor

Prof. Murray Fingeret, OD

Prof. Murray Fingeret, OD
Advisory Board Member

Prof. Robert Weinreb, MD

Prof. Robert Weinreb, MD
Advisory Board Member

Our Partners

eHealth Ventures

News & Events

New Clinical Site Added

Ophthalmic Sciences has initiated recruitment at Assuta Hashalom, the country’s busiest eye clinic, also marking the testing initiation of its most advanced prototype
Assuta Hashalom

Company Presenting at the 2022 Glaucoma 360 Event

Ophthalmic Sciences is presenting its technology and early clinical results on February 11, 2022 at the Glaucoma 360 event. Read more

Ariel Weinstein, MSc

Having over 25 years of medical industry experience with the most recent 15 years of which in corporate leadership, Mr. Weinstein has hands-on expertise in the business and with taking complex drug-device products from concept to market. He holds an MSc in Management from NYU, and a BSc in Emergency Medicine from Ben Gurion University, Israel.

Noam Hadas, MA, Msc
Founder & CTO

Mr. Hadas is a successful entrepreneur and inventor, with over 30 years’ experience in medical device research and development. He holds an MA in Industrial Design, Medical Devices from The Technion, Israel and an MSc in Electronic Engineering from Tel Aviv University, Israel.

Dr. Joseph Rosenblum, MD
Medical Director

Dr. Rosenblum is the Director of the Medical Informatics Department at Maccabi Healthcare Services and is one of the early pioneers in the field of Medical Informatics. He is a Board Member of several medical startups and a lecturer at the Sackler School of Continuing Medical Education and the Israeli Extension of Clark University.

Prof. David Goldblum, MD
Board Member & Senior Advisor

A Professor at the University of Basel, Prof. Goldblum is also the CMO of Pallas-Kliniken, the largest eyecare clinic network in Switzerland. An acclaimed ophthalmologist specializing in anterior segment and oculoplasty he has a strong interest in novel eyecare technology.

Prof. Murray Fingeret, OD
Advisory Board Member

Prof. Murray Fingeret is Chief of the Optometry Section, Brooklyn/St. Albans Campus, Department of Veterans Administration New York Harbor Health Care System. Prof. Fingeret is a Clinical Professor at the State University of New York, College of Optometry and a fellow of the American Academy of Optometry. Prof. Fingeret was inducted into the National Optometry Hall of Fame in 2019 and sits on the Board of Directors of the Glaucoma Foundation. He is a member of the American Glaucoma Society, the American Optometric Association, and the National Academies of Practice.
Prof. Fingeret is a founding member and past-president of the Optometric Glaucoma Society and currently the president of the Optometric Glaucoma Foundation. He is the recipient of the 2013 Vincent Ellerbrock Clinician Educator Award from the American Academy of Optometry, 2008 Distinguished Service Award Optometric Glaucoma Society, 2005 Carel C. Koch Memorial Medal from the American Academy of Optometry, 1999 AMSUS Federal Service Optometrist of the Year award and 1996 Otsuka Glaucoma Educators Award from the American Academy of Optometry. Prof. Fingeret sits on the editorial boards for the Journal of Glaucoma, International Glaucoma Review, Glaucoma Today, Primary Care Optometry News, Optometry Times and Review of Optometry and has authored numerous articles and co-authored the texts “Atlas of Primary Eyecare Procedures” and “Primary Care of the Glaucomas”.

Prof. Robert Weinreb, MD
Advisory Board Member

Prof. Weinreb is the Distinguished Professor and Chair of Ophthalmology at the University of California, San Diego. He is also Director of the Shiley Eye Institute, Director of the Hamilton Glaucoma Center, holder of the Morris Gleich, MD Chair of Glaucoma and is appointed as Distinguished Professor of Bioengineering.

Prof. Weinreb received his medical degree from Harvard Medical School, and was both a resident and fellow at the University of California, San Francisco. He has trained more than 150 post-doctoral Fellows in Glaucoma, including 21 Chairs and many others who hold distinguished academic positions in the United States and throughout the world. Prof. Weinreb is past President of the American Glaucoma Society (AGS), the Association for Research in Vision and Ophthalmology (ARVO), the Foundation of the American Glaucoma Society, the World Glaucoma Association (WGA), and the Latin American Glaucoma Society. The recipient of numerous awards and prizes, he has been ranked #1 world glaucoma for several consecutive years for by Expertscape.

Our pilot study is underway!
Ophthalmic Sciences is working with Assuta Medical Center in Ashdod and Assuta Hashalom on the study of its novel glaucoma monitoring technology, see our news section for study details.
Contact us for more information.

הניסוי הראשון שלנו יוצא לדרך!
אופטלמיק סאיינסס בשיתוף עם בי”ח אסותא אשדוד ואסותא השלום מקיימים ניסוי בטכנולוגיה חדשנית למדידת לחץ תוך עיני ללא מגע לחולי גלאוקומה או לאלו החשודים כחולים.
צרו איתנו קשר במידה ואתם מעוניינים לקבל מידע נוסף.